Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 206 of 5804
-
New hope for brain infection: experimental combo tackles tuberculous meningitis
Disease control Not yet recruitingThis two-stage study will compare consented research participants with tuberculous meningitis receiving BPaLMZ to controls receiving SOC of rifampicin (R), isoniazid (H), pyrazinamide (Z), and ethambutol (E), known as RHZE.
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
AI app aims to stop diabetes in pregnancy before it starts
Prevention Not yet recruitingThe goal of this pragmatic randomized controlled trial is to evaluate the effectiveness of an AI-enabled mobile health management application ("Better Pregnancy" app), grounded in the Theory of Planned Behavior, in preventing gestational diabetes mellitus (GDM) among pregnant wom…
Phase: NA • Sponsor: Fangbiao Tao • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
Can bringing addiction treatment to syringe programs save more lives?
Disease control Not yet recruitingThis study is testing whether offering buprenorphine treatment directly at syringe service programs (SSPs) helps more people start and stay in treatment for opioid use disorder (OUD) than referring them to community buprenorphine treatment providers. Buprenorphine is a medication…
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New weekly shot could help control diabetes and weight
Disease control Not yet recruitingThis multicenter, randomized, double-Blind, parallel-group, placebo-controlled phase III trial is to evaluate the efficacy and safety of UBT251 Injection in patients with Type 2 Diabetes Mellitus with inadequate glycemic control on diet and exercise alone
Phase: PHASE3 • Sponsor: The United Bio-Technology (Hengqin) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Brain implant zaps depression without wires
Disease control Not yet recruitingThe objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif XCS System when used as indicated for treatment-resistant depression (TRD).
Phase: NA • Sponsor: Motif Neurotech, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a gentler antifungal drug protect liver transplant patients from deadly mold without risking organ rejection?
Disease control Not yet recruitingInvasive mold diseases (IMD) carry extremely high mortality rates in liver transplant recipients (aspergillosis prevalence \~1.8%, mortality 60%-90%; mucormycosis prevalence \~2%, mortality 38%-95%). Guidelines emphasize early antifungal therapy: liposomal amphotericin B (L-AmB) …
Phase: NA • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Head-to-Head: which JAK inhibitor wins for myelofibrosis patients with low blood counts?
Disease control Not yet recruitingThe purpose of this study is to compare momelotinib and ruxolitinib as treatments for myelofibrosis with low blood cell counts. Both drugs are approved by the FDA to treat myelofibrosis. The study asks which drug does a better job at shrinking the spleen.
Phase: PHASE4 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug combo aims to shrink Hard-to-Treat lung tumors
Disease control Not yet recruitingThis phase II Expanded Lung-MAP treatment trial compares how well sacituzumab govitecan alone, ivonescimab alone, or sacituzumab govitecan in combination with ivonescimab works in treating patients with non-small cell lung cancer (NSCLC) that has come back after a period of impro…
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Brain scan breakthrough: amino acid PET may solve a tricky diagnosis dilemma
Diagnosis Not yet recruitingDifferentiating radiation necrosis from tumor progression in patients with brain metastases has a major therapeutic and prognostic implications
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jul 19, 2026 00:00 UTC
-
New heart device aims to tame persistent AFib
Disease control Recruiting nowThe purpose of this study is to assess how safe VARIPULSE catheter system is for treatment of a heart rhythm disease called persistent atrial fibrillation (PsAF) in participants who are having a catheter ablation procedure (treat heart rhythm disease). This includes isolation of …
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New combo shot CagriSema takes on childhood diabetes
Disease control Not yet recruitingThe purpose of this clinical study is to look into how well a study medicine called CagriSema helps children and adolescents living with diabetes lower their blood sugar and body weight. The study has 2 parts: in the first part participant will get either CagriSema or placebo, an…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Could a nose spray and walking protect the aging brain?
Disease control Recruiting nowAbout 6.5 million adults in the United States who are 65 or older have dementia. While the exact cause of dementia is not known, it may be due to changes in the brain. Further, risk may be higher when the brain does not respond to insulin. Indeed, brain insulin resistance has em…
Phase: PHASE2, PHASE3 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Simple antibacterial wash could slash deadly graft infections in vascular surgery
Prevention Not yet recruitingThis is a study of the use of an antibacterial solution, Hypochlorous acid, to prevent infection in vascular surgery bypass grafts. The solution will be used at the end of operations to insert a prosthetic vascular surgery bypass graft, to wash the wound and the vascular bypass g…
Phase: NA • Sponsor: Hamilton Health Sciences Corporation • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
New hope for kids with tough leukemia: transplant plus CAR t cells
Disease control Recruiting nowThe purpose of this study is to learn more about newer methods of transplanting blood cells donated by a partially matched family member to children with high-risk CD19 positive leukemia ALL. Primary Objective: \- To assess the safety and feasibility of combining CD19-CAR(Mem) …
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Cord blood cells aim to break transfusion dependence in aplastic anemia
Disease control Not yet recruitingThis Phase 2, multicenter, open-label study is evaluating CK0801 for the treatment of aplastic anemia in adults with persistent transfusion dependence after at least one prior line of therapy or intolerance to standard-of-care treatment. CK0801 is an allogeneic cord blood-derived…
Phase: PHASE2 • Sponsor: Cellenkos, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New dosing strategy aims to reduce eye side effects in myeloma treatment
Disease control Not yet recruitingThe aim of this study is to assess safety, efficacy and pharmacokinetic (PK) parameters with alternative dosing schedules of belantamab mafodotin in combination with bortezomib and dexamethasone compared to the approved dosing regimen in participants with relapsed or refractory m…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Video visits may help seniors bounce back from frailty after hospitalization
Disease control Not yet recruitingThe goal of this clinical trial is to learn if a structured tele-consultation program, delivered 3 times over 12 weeks, can improve (reverse) frailty in geriatric patients recently discharged from the hospital. The main questions it aims to answer are: * Does structured tele-con…
Phase: NA • Sponsor: Indonesia University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Veterans test daily cream to stop face skin cancers
Prevention Not yet recruitingThis is an intent-to-treat, parallel design, multicenter randomized trial and the primary intervention is a double-blind comparison of Imiquimod (IMQ) vs. placebo cream for preventing basal cell carcinoma (BCC) of the skin on the face at one year and over 3 years after therapy. P…
Phase: PHASE3 • Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
New antibody injection could stop gout flares while lowering uric acid
Disease control Not yet recruitingThe purpose of this study is to determine the efficacy and safety of recombinant anti-interleukin-1β humanized monoclonal antibody injection in Chinese gout participants Initiating Urate-Lowering Treatment
Phase: PHASE2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a daily pill shield transplant patients from a common virus?
Prevention Not yet recruitingThe purpose of this clinical trial is to find out whether a medication, called letermovir, can help prevent a virus called cytomegalovirus (CMV) in participants who receive a kidney or liver transplant and who have already been exposed the CMV. Participants will take letermovir …
Phase: PHASE4 • Sponsor: University of Wisconsin, Madison • Aim: Prevention
Last updated Jul 17, 2026 00:00 UTC